DaVita (MEX:DVA) PE Ratio without NRI: 15.62 (As of Jul. 02, 2026) — Near Median


MEX:DVA DaVita Inc MEX:DVA
80 GF Score
Price MXN3,358.09
GF Value MXN2,564.33
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita PE Ratio without NRI?

DaVita MEX:DVA 80 PE Ratio without NRI is 15.62 as of Jul. 02, 2026, which is 2% above its 10-year median of 15.26. GuruFocus rates MEX:DVA with a GF Score™ of 80/100 and a GF Value™ of MXN2,564.33 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 439 Healthcare Providers & Services companies, DaVita ranks better than 50.8% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-02), DaVita's share price is MXN3358.09. DaVita's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was MXN214.56. Therefore, DaVita's PE Ratio without NRI for today is 15.62.

During the past 13 years, DaVita's highest PE Ratio without NRI was 24.84. The lowest was 8.98. And the median was 15.26.

DaVita's EPS without NRI for the three months ended in Mar. 2026 was MXN51.75. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was MXN214.56.

As of today (2026-07-02), DaVita's share price is MXN3358.09. DaVita's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN196.99. Therefore, DaVita's PE Ratio (TTM) for today is 17.03.

Warning Sign:

DaVita Inc stock PE Ratio (=21.15) is close to 5-year high of 21.63.

During the past years, DaVita's highest PE Ratio (TTM) was 80.27. The lowest was 8.65. And the median was 15.88.

DaVita's EPS (Diluted) for the three months ended in Mar. 2026 was MXN51.75. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN196.99.

DaVita's EPS (Basic) for the three months ended in Mar. 2026 was MXN52.84. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN201.01.


DaVita  (MEX:DVA) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


DaVita PE Ratio without NRI Related Terms


DaVita PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for DaVita's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita PE Ratio without NRI Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.46 11.31 12.37 15.45 10.54

DaVita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.24 14.57 13.70 10.54 13.10

MEX:DVA vs THC, EHC, ENSG: PE Ratio without NRI Comparison

For the Medical Care Facilities subindustry, DaVita's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where DaVita's PE Ratio without NRI falls into.


MEX:DVA
80GF Score
DaVita Inc MEX:DVA
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

DaVita's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=3358.09/214.933
=15.62

DaVita's Share Price of today is MXN3358.09.
DaVita's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN214.56.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 15.62 mean?
DaVita (MEX:DVA) has a PE Ratio without NRI of 15.62 as of Jul. 02, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on DaVita and its competitors. This is near median its historical median of 15.26. Over the past decade, DaVita's PE Ratio without NRI has ranged from 8.98 to 24.84. According to the industry distribution chart, DaVita ranks #216 out of 439 companies in the Healthcare Providers & Services industry, placing it in the top 49.2%.
Is DaVita's PE Ratio without NRI too high?
DaVita's current PE Ratio without NRI of 15.62 is near median its 10-year median of 15.26. Over the past 10 years, this metric has ranged from a low of 8.98 to a high of 24.84. The Healthcare Providers & Services industry median PE Ratio without NRI is 19.75. DaVita's value of 15.62 is 20.9% below this industry median. Based on the distribution chart, DaVita ranks #216 out of 439 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, DaVita has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's PE Ratio without NRI compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #216 out of 439 companies for PE Ratio without NRI. This puts DaVita in the upper half of its industry. The industry median PE Ratio without NRI is 19.75. DaVita's value of 15.62 is 20.9% below this benchmark. Historically, DaVita's own PE Ratio without NRI has ranged from 8.98 to 24.84 over the past decade. While the company's 10-year median is 15.26 vs. the industry median of 19.75, DaVita has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Providers & Services company?
The median PE Ratio without NRI among Healthcare Providers & Services companies is 19.75, based on 439 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaVita's current PE Ratio without NRI of 15.62 is 20.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on DaVita and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio without NRI is 19.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaVita's current PE Ratio without NRI is 15.62, which is near median its own 10-year median of 15.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MEX:DVA) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN2,564.33, compared to a current price of MXN3,358.09 — trading 31% above its estimated fair value. The current PE Ratio without NRI is 15.62, which is near median its 10-year median of 15.26 and 20.9% below the Healthcare Providers & Services industry median of 19.75. DaVita's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For DaVita (MEX:DVA), the current PE Ratio without NRI is 15.62 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (MEX:DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of MXN3,358.09 is trading 31% above its estimated GF Value™ of MXN2,564.33. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for MEX:DVA:

  • PE Ratio without NRI: 15.62 (near median its 10-year median of 15.26)
  • GF Value™: MXN2,564.33 vs. price of MXN3,358.09 (31% above fair value)
  • GF Score™: 80/100 with 6 warning signs
  • Industry Position: 20.9% below the Healthcare Providers & Services median (#216 of 439)

No single metric tells the full story. See the MEX:DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
80GF Score

Get the complete analysis for MEX:DVA

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,358.09
Price
MXN2,564.33
GF Value